Delaware
GSK stock climbs on Delaware court ruling in Zantac case
GSK (GSK) stock was up 3% Tuesday following a Delaware court ruling on whether certain evidence should be allowed in an ongoing case over the safety of its recalled drug Zantac.
![GSK stock climbs on Delaware court ruling in Zantac case](https://america.easybranches.com/uploads/news/2024/08/18433318.jpg)
Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!
Easy Branches
34/17 Moo 3 Chao fah west Road, Phuket, Thailand, PhuketCall: 076 367 766
info@easybranches.comGSK (GSK) stock was up 3% Tuesday following a Delaware court ruling on whether certain evidence should be allowed in an ongoing case over the safety of its recalled drug Zantac.